INSIGHTS ON DRUG DEVELOPMENT
-
Overcoming Challenges In Ophthalmic Formulations
Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.
-
Cracking Complexity: Leveraging Lessons Learned For Future Bispecific Development
The shift from static platforms to adaptive, knowledge-driven development helps biopharma teams manage BsAb complexity, accelerate analytical, purification, and formulation development, and improve IND readiness.
-
Advancing Drug Safety And Improving R&D Productivity With The Liver-Chip S1
Explore how the Emulate Liver-Chip S1 revolutionizes predictive toxicology by mimicking human liver biology, achieving superior sensitivity and specificity.
-
Closing The QC Gap For mAbs: Rapid Answers Without Compromising
Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.
-
How Do You Start Process Transfer For A New Client?7/23/2026
Anmaris Torres, Process Engineering Team Leader, on why a process transfer starts with a conversation across departments to figure out how to cut cycle time before commercial production begins.
-
Overcoming Challenges In Ophthalmic Formulations Through Polymer Selection8/27/2025
The growing demand for ophthalmic drugs is driven by aging populations and increased screen time, which contributes to rising eye conditions. Explore innovative solutions in ophthalmic drug development.
-
A Sensory Panel Study With The Focus On High-Intensity Sweeteners8/5/2026
Gain insight into the sensory performance of five high-intensity sweeteners in a simulated bitter formulation, including their effects on sweetness, bitterness, aftertaste, and covering ability.
-
Enabling Quality By Design9/8/2025
Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.
-
A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics11/7/2025
Learn about a streamlined workflow that improves reproducibility, reduces contamination, and simplifies single-cell proteomics with comparable results to FACS.
DRUG DEVELOPMENT SOLUTIONS
-
Explore immunoassays and LC-MS kits for over 30 clinical areas, each with detailed specifications and broad sample compatibility for precise, high-throughput biomarker analysis.
-
Cambrex’s understanding of crystal formation and thermodynamics allows us to develop custom, scalable crystallization processes for peptides. We leverage the right tools with the best experts to bridge success from the bench to the plant.
-
Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.
-
Re-engineer your drug's path into clinical development and accelerate time to Proof-of-Concept. Real-time data guides rapid formulation iterations, minimizing drug substance use and lowering program risk.
-
Discover the benefits of partnering with a CDMO that offers expanding capacity and capabilities and a far-reaching operational footprint to support your project.